VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KINS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KINSKingstone Companies, Inc.
$19.27$279M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKINSQuarterly Financials

Kingstone Companies, Inc. (KINS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kingstone Companies, Inc. (KINS) quarterly income statement — complete revenue, gross profit & net income history

KINS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue59.78M40.75M55.65M52.29M50.5M42.1M40.77M36.5M35.77M36.61M34.24M36.72M36.63M37.09M35.54M28.98M28.55M43.17M38.96M39.6M
Revenue Growth %18.37%-3.22%36.5%43.27%41.2%15.02%19.09%-0.59%-2.35%-1.31%-3.66%26.71%28.29%-14.08%-8.78%-26.82%-27.72%21.25%11.88%14.16%
Medical Costs & Claims45.59M-12.32M31.54M28.56M36.49M26.35M22.03M14.24M25.71M24.44M30.14M28.05M33.58M33.81M30.73M27.14M31.29M31.32M43.94M29.04M
Medical Cost Ratio %76.27%-30.23%56.67%54.61%72.26%62.58%54.04%39.01%71.89%66.76%88.04%76.39%91.68%91.16%86.47%93.64%109.6%72.54%112.79%73.34%
Gross Profit14.19M53.07M24.11M23.74M14.01M15.75M18.74M22.26M10.05M12.17M4.09M8.67M3.05M3.28M4.81M1.84M-2.74M11.85M-4.98M10.56M
Gross Margin %23.73%130.23%43.33%45.39%27.74%37.42%45.96%60.99%28.11%33.24%11.96%23.61%8.32%8.84%13.53%6.36%-9.6%27.46%-12.79%26.66%
Gross Profit Growth %1.26%236.86%28.67%6.62%39.36%29.48%357.76%156.85%229.78%271.09%-14.85%370.54%211.22%-72.34%196.46%-82.55%-131.44%14.92%-174.75%-25.22%
Operating Expenses21.59M34.61M10.41M9.57M9.29M9.07M9.66M16.54M8.25M8.27M8.49M9.23M9.35M8.21M9.37M8.62M8.92M8.84M8.69M8.92M
OpEx / Revenue %36.11%84.94%18.7%18.3%18.4%21.55%23.68%45.32%23.06%22.59%24.8%25.14%25.53%22.14%26.36%29.76%31.26%20.48%22.32%22.53%
Depreciation & Amortization716K677.96K644.65K613.36K623.86K613.43K619.06K619.93K596.51K645.75K741.06K778.5K808.13K828.1K824.98K877.26K770.11K810.36K820.09K837.65K
Combined Ratio %112.38%54.71%75.37%72.91%90.66%84.14%77.72%84.33%94.95%89.35%112.84%101.53%117.21%113.31%112.83%123.4%140.86%93.02%135.11%95.87%
Operating Income-7.4M18.45M13.71M14.17M4.72M6.68M9.08M5.72M1.8M3.9M-4.4M-563.42K-6.3M-4.94M-4.56M-6.78M-11.67M3.01M-13.68M1.64M
Operating Margin %-12.38%45.29%24.63%27.09%9.34%15.86%22.28%15.67%5.05%10.65%-12.84%-1.53%-17.21%-13.31%-12.83%-23.4%-40.86%6.98%-35.11%4.13%
Operating Income Growth %-256.86%176.3%50.88%147.66%161.45%71.34%306.62%1115.25%128.63%178.99%3.57%91.69%45.96%-263.76%66.67%-514.7%-2973.59%39.8%-626.13%-70.64%
EBITDA-6.68M19.13M14.35M14.78M5.34M7.29M9.7M6.34M2.4M4.54M-3.66M215.08K-5.5M-4.11M-3.73M-5.91M-10.9M3.82M-12.86M2.47M
EBITDA Margin %-11.18%46.95%25.79%28.26%10.58%17.32%23.8%17.37%6.71%12.41%-10.68%0.59%-15%-11.07%-10.51%-20.38%-38.16%8.86%-33.01%6.25%
Interest Expense70K68.08K72.61K77.07K227.45K629.47K900.58K989.72K993.88K997.97K988.7K1.01M1.01M649.41K456.55K456.55K456.55K456.55K456.55K456.55K
Non-Operating Income0-68.08K-72.61K-77.07K-227.45K-629.47K-900.58K-989.72K-993.88K-997.97K-988.7K-1.01M-1.01M-649.41K-456.55K-456.55K-456.55K-456.55K-456.55K-456.55K
Pretax Income-7.4M18.45M13.71M14.17M4.72M6.68M9.08M5.72M1.8M3.9M-4.4M-563.42K-6.3M-4.94M-4.56M-6.78M-11.67M3.01M-13.68M1.64M
Pretax Margin %-12.38%45.29%24.63%27.09%9.34%15.86%22.28%15.67%5.05%10.65%-12.84%-1.53%-17.21%-13.31%-12.83%-23.4%-40.86%6.98%-35.11%4.13%
Income Tax-1.59M3.69M2.83M2.91M835.68K1.24M2.11M1.21M378.02K952.18K-858.99K-41.41K-1.25M-985.04K-561.67K-1.4M-2.47M785.97K-3.06M312.15K
Effective Tax Rate %21.52%20.02%20.67%20.57%17.71%18.57%23.18%21.07%20.95%24.43%19.54%7.35%19.81%19.96%12.32%20.68%21.16%26.08%22.38%19.09%
Net Income-5.81M14.76M10.87M11.25M3.88M5.44M6.98M4.51M1.43M2.95M-3.54M-522.02K-5.05M-3.95M-4M-5.38M-9.2M2.23M-10.62M1.32M
Net Margin %-9.72%36.22%19.54%21.52%7.69%12.92%17.12%12.37%3.99%8.05%-10.33%-1.42%-13.8%-10.65%-11.25%-18.56%-32.21%5.16%-27.26%3.34%
Net Income Growth %-249.59%171.38%55.81%149.22%172.15%84.62%297.26%964.9%128.22%174.58%11.51%90.3%45.04%-277.31%62.35%-506.51%-2856.48%-26.63%-764.78%-71.28%
EPS (Diluted)-0.401.030.740.780.270.400.550.370.120.27-0.33-0.05-0.47-0.37-0.38-0.51-0.870.21-1.010.12
EPS Growth %-248.15%157.5%34.55%110.81%125%48.15%266.67%862.89%125.53%172.97%13.16%90.49%45.98%-276.19%62.38%-525%-2889.69%-25%-741.67%-72.09%
EPS (Basic)-0.401.040.770.810.290.440.610.410.130.27-0.33-0.05-0.47-0.37-0.38-0.51-0.870.21-1.010.12
Diluted Shares Outstanding14.45M14.38M14.6M14.39M14.27M13.49M12.58M12.11M11.79M10.76M10.76M10.76M10.76M10.59M10.65M10.64M10.63M10.52M10.52M10.85M